FilingFirehose · free AI preview
MapLight Therapeutics, Inc.
MPLT · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
MapLight Therapeutics (MPLT) reported one officer departure via 8-K filing in late April 2026, with no detected cyber incidents in the past 90 days. While this recent executive change warrants context around timing and strategic implications, a single event in a short window provides limited visibility into operational stability or capital structure risk. The full $49 Report adds dilution risk scoring, 12-month filing history, financing trajectory analysis, and AI-detected signals that contextualize whether this departure reflects routine transition or deeper governance concerns.
Want the full 5-section $49 Report on MPLT?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.